To cure today's most devastating diseases, pharmaceutical companies are researching stem cell-based therapies. However, current stem cell sources are unsuitable due to logistical, ethical and technical limitations. Factor Bioscience provides pharmaceutical companies with highly characterized stem-cell libraries for drug screening and regenerative medicine development.